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Abstract:
Adults with intellectual and developmental disabilities (I/DD) are now regularly reaching old age, and are increasingly presenting to their health care providers with concerns related to growing older. One particularly challenging clinical question is related to the evaluation of suspected cognitive decline and potential dementia in older adults with I/DD, a question that most physicians feel ill-prepared to answer or address. The National Task Group on Intellectual Disabilities and Dementia Practices (NTG) was convened to help formally address this topic, which remains largely underrepresented in the medical literature. The task group, comprised of specialists who work extensively with adults with I/DD, has promulgated the following Consensus Recommendations for the Evaluation and Management of Dementia in Adults with Intellectual Disabilities as a framework for the practicing physician who seeks to approach this clinical question practically, thoughtfully, and comprehensively.
Introduction: The National Task Group (NTG) on Intellectual Disabilities and Dementia Practices
The National Task 
Strategy for Enabling Adults with Intellectual Disabilities Affected by Dementia to
Remain in Their Community and Receive Quality Supports." 2 A subgroup of the task group was formed to focus specifically on health practices. The guidelines and recommendations outlined in this document represent the consensus reached amongst said specialists at two plenary meetings and ongoing discussions that followed, informed by review of current literature and drawn from each specialist's clinical practice, and thus meet level 2 (case-controlled studies) and level 3
(observational studies) for evidence in clinical application. These guidelines are a suggested starting point as we develop more formal methodologies to determine bestpractices of evaluation of dementia in this population.
Background
Adults with intellectual and developmental disabilities (I/DD) are now regularly living into old age, with many surviving into their 70s, 80s and beyond. Dementia is among the most clinically challenging co-occurring conditions of aging among a select group within this population (i.e., those adults with Down syndrome and those with brain injury), considering that the approach to evaluation, diagnosis, treatment, and management of dementia in adults with I/DD remains largely undefined in the literature.
It has been well established that adults with I/DD experience poorer health outcomes compared to the general population, a trend seen in mortality, morbidity, and quality of life. 3, 4 The cause of this disparity is complex and multifactorial, but poor training and preparedness among health care providers nationwide ranks among the key contributing factors. Formal didactic training on adults with I/DD throughout the lifespan is not routinely incorporated into U.S. medical school or residency training. 5 Recognizing these existing disparities in medical training and health care services for adults with I/DD, the National Task Group on Intellectual Disabilities and Dementia
Practices organized a targeted effort to help address this gap. The goal of this paper is to clarify key principles of evaluation and management of dementia in adults with I/DD (which, for the purpose of this paper, refers to individuals 20 and older), based on evidence-based research as well as consensus among experts within the NTG.
Prevalence of dementia in intellectual disability
In Down syndrome, one of the most common forms of intellectual disability, the underlying genetic link between trisomy 21 and Alzheimer's disease has been convincingly established. 6, 7 By age 40, all adults with Down's syndrome demonstrate some degree of neuropathologic defects postmortem that meet criteria for Alzheimer's disease. 8, 9 While specific prevalence estimates may vary, generally it is accepted that approximately at minimum 50% of adults age 60 and older will evidence dementia clinically. 10, 11, 12 Thus, the development of clinical Alzheimer's disease is not inevitable in aging adults with Down syndrome, although risk increases incrementally with age.
In these practice guidelines we take an encompassing approach and generalize recommendations onto the broad population with intellectual and developmental disabilities, recognizing that distinct genetic and neurological factors associated with specific conditions may compromise these generalizations.
Specific challenges within the aging population in I/DD
One of the hallmark features of all causes of dementia is a decline from baseline level of function and performance of daily skills. While this is usually relatively straightforward to establish in the general population, this can be a much more complicated task in adults with intellectual disability because of variance in cognitive functioning. This is particularly true to the current generation of older adults with I/DD due to a variety of factors, including: poor record-keeping from childhood, lack of ongoing involvement from family, and involvement of multiple staff members (often due to a high degree of turnover), and inconsistencies in the physician-patient relationship that obviates knowing the person over his or her lifespan. 13 In the absence of a personal historian who is able to accurately and comprehensively attest to an individual's baseline level of functioning, the assessment of a reported or observed change may be exponentially more complicated. The early signs of dementia in adults with I/DD can be subtle and often require an astute observer to identify these changes proactively. Often individuals with I/DD are served by numerous caregivers throughout their lifetime, and often newly involved care providers will presume that their current level of ability represents their baseline level of functioning, and thus miss signs of early decline. Act. 18, 19 The following guidelines also address this process and offer suggestions on how to meet this requirement.
Evaluation
History is the cornerstone of a dementia diagnosis. It is important that a thorough and comprehensive history be conducted to compile evidence consistent with an emerging dementia while probing for other features or patterns that might suggest other contributing factors. Pertinent historical information is particularly useful from personal accounts of caregivers and family members who have known the individual for several years. In addition, other sources of information such as previous neuropsychological testing or school IEP information can greatly assist in accurately characterizing and individual's baseline. One model for obtaining such a history is elaborated in a separate NTG publication regarding community supports. 20 To perform the evaluation process,
we recommend the following 9-step approach.
Step 1: Gather pertinent medical and psychiatric history. A thorough history should include, of course, a review of past medical and psychiatric history, with particular attention to issues of one's personal health that could potentially influence likelihood for development of a premature dementia. These include:
 history of cardiovascular disease  history of cerebrovascular disease or stroke  known underlying neurologic structural abnormalities  history of head injury, concussion, loss of consciousness  poorly treated sleep disorders or thyroid disease, vitamin B12 deficiency, metabolic syndrome (obesity, diabetes, hypertension)
Step 2: Obtain a historical description of baseline functioning. As discussed earlier, a dementia diagnosis requires evidence of change from a prior level of functioning, and this 'baseline' is quite individualized in people with I/DD. This is highly dependent on the historian, and thus a family member or caregiver who knows the individual well should be present for this interview.
Supplemental Table 1 outlines the key factors to review when constructing a historical baseline for an individual undergoing assessment for dementia (available online at http://www.mayoclinicproceedings.org)
Step 3: Obtain a description of current functioning and compare to baseline.
Information-gathering regarding current functioning is obtained in a similar fashion as was done in the historical baseline, allowing a side-by-side comparison of scope and degree of change over time. This practice helps systematically assess for the key criteria of dementia, specifically: "dementia is diagnosed when there are cognitive or behavioral symptoms that 1) interfere with the ability to function at work or at usual activities; and 2) represent a decline from previous levels of functioning and performing." 21 Key features to look for included reported memory loss or impairment, significant changes in personality, disorientation, and decreasing performance in expected tasks/skills.
Step 4: Perform a focused review of systems. A focused review should take an inventory of common issues that are seen with increasing age and also with possible emerging dementias. Supplemental Table 2 summarizes the system areas that should be highlighted in an assessment of an adult with I/DD (available online at http://www.mayoclinicproceedings.org)
Step 5: Review the medication list thoroughly. Medications require specific focus, as the risk of polypharmacy and the involvement of multiple prescribing providers increases with advancing age. Special attention should be paid to all newly-added medications, particularly those that are psychoactive, antiepileptic, or anticholinergic, as well as those with sedating properties. Common side effects and drug-drug interactions should be reviewed, with attention paid to non-specific signs and symptoms that might suggest a drug side effect, such as somnolence, gait instability, urinary retention, to name a few. Table 1 lists commonly used medications with potential deleterious effects on cognition in this population.
Insert Table 1 about here Step 6: Obtain pertinent family history. Family history is important primarily for detecting a history of dementia in first-degree relatives, particularly if the disease presented prematurely (generally under age 50, except among adults with Down syndrome), suggesting a stronger possible familial predisposition. Additional factors of note include: history of cerebrovascular disease, stroke, diabetes, heart disease, and rheumatoid arthritis or systemic lupus erythematosus (SLE) in first-degree relatives.
Step 7: Assess for other psychosocial issues or changes. Aging adults with I/DD often confront a wide variety of potentially destabilizing life events merely by virtue of growing older. These events may include: leaving the family home, witnessing the declining health or death of a parent, loved one, or friends/housemates, decline in one's own health, functionality, or employment status, or frequent turnover/departure of caregivers. The cumulative impact of these events in an adult with I/DD who may have limited coping skills or emotional maturity cannot be overstated. A careful assessment for these factors could identify certain triggering events and frequently also help in the identification of other coexisting mood disorders, such as untreated anxiety or depressed mood, which could be strongly influencing an individual's cognitive and functional performance.
Psychiatric illness may present atypically in adults with I/DD and there is a common pitfall of diagnostic overshadowing, where features truly related to an underlying mental illness are instead attributed to the individual's intellectual disability. The method of history taking described above helps account for changes in baseline mood, behavior, or personality, which should raise red flags for a possible emerging psychiatric/mental health disorder. Pay close attention to the review of systems to highlight other potential neurovegetative signs of appetite changes, weight loss, and change in sleep patterns.
In Down syndrome, depression and other prefrontal lobe symptoms may be more common in dementia. These include signs and symptoms of: indifference, uncooperativeness, apathy, depression and socially deficient communication or impaired adaptive functioning in general. 22 For a review of features of mental disorders that may present atypically in adults with I/DD, the Dementia Manual -Intellectual Disability (DM-ID) is a particularly helpful desk reference.
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Step 8: Review social history, living environment, and level of supports. Assessment of current living conditions and level of support is increasingly critical when an emerging dementia is suspected, as evaluation of safety concerns and appropriateness of one's current placement is a priority. Even if current supports appear to be adequate it is important to think proactively in the setting of a suspected dementia, knowing that there will be ever-changing and increasing needs.
Step 9: Synthesize the information. As the history and all supporting data are obtained in a stepwise fashion, the interviewer is advised to continually mentally cross-reference the information with the criteria for a dementia diagnosis, building a case of evidence for or against the diagnosis. By the end of the history taking a fairly strong level of suspicion should already be built.
Physical Examination
A physical examination in the setting of a suspected dementia should keep a keen eye out for physical findings that may suggest underlying medical issues that may be contributing to the patient's current presentation. Supplemental Table 3 summarizes the key components of focus during an office examination for suspected dementia (available online at http://www.mayoclinicproceedings.org).
Cognitive Assessment
Currently 30 Regardless of the clinician's choice of instrument, the focus should be centered on recognizing change and decline in relation to a premorbid baseline.
In addition, the initial interview and exam can be adapted to assess performance in a variety of cognitive domains. This could be performed in the office or at the bedside if questions are flexible enough to be appropriate for the individual's baseline intellectual ability. To further enhance the information provided by the test batteries suggested above, providers are encouraged to include additional questioning to assess the individual's general orientation, writing/writing/math skills (if applicable), naming abilities (body parts, common objects), basic motor skills, general knowledge (counting, days of the week), language comprehension, and recall of newly learned information. All of these components could be fairly easily added to a provider's questioning repertoire and can help point to changes if abilities decay over subsequent visits.
Diagnosis
There exists great heterogeneity in adults with I/DD and thus there is no basis for comparison against any other set of peer-based percentiles, standards, or generalized sets of expectations when assessing an individual for dementia. Assessment of decline should always be individualized and patient-specific, with judgments made based on a deterioration from the patient's own individual baseline level of intellectual disability, function, and achievement (i.e., their 'personal best').
A dementia diagnosis should never be arrived upon at the expense of a proper investigation into other contributing factors that are potentially correctable. There are several co-occurring issues that frequently masquerade as dementia or negatively compound the effects of an early dementia. Table 2 summarizes these common conditions that should be assessed during a general evaluation in an effort to identify contributors, and more importantly, to look for elements that can be treated or improved.
Insert Table 2 about here The workup following an office cognitive assessment should be customized to the specific signs and concerns of each individual patient. Further assessment of one or more of the above components may comprise the "homework" that a patient's caregiver or referral agency may be instructed to complete following their first assessment.
Laboratory testing is justifiable in nearly every patient seeking cognitive assessment, as blood work is potentially high-yield for uncovering or ruling out multiple common conditions that might influence cognition. and treatment for suspected underlying pain, discomfort, and mobility difficulties.
Occupational and physical therapy consults should be considered in helping to enable the individual and care staff in helping with current difficulties in ADLs and trying to sustain current levels of function.
Pharmacologic treatment of dementia comprises only a portion of the treatment plan.
The large majority of the treatment approach should be non-pharmacologic, via communication and environmental and behavioral strategies. This topic is addressed and outlined in rigorous detail in Jokinen et al, 2013, another publication by the NTG.
Follow up
At the conclusion of the initial assessment, it is recommended that a follow-up visit be planned with the goal of reviewing results of requested studies and to assess response to any recommended interventions. If there is any question, it is often prudent to suspend any formal diagnosis of dementia until at least the second meeting, to allow for proper investigation into other contributing factors in the intervening months.
There is no consensus or formal framework by which a provider treating an individual with I/DD can judge an individual's response to dementia treatment. Outcome measures used in drug studies for adults with Down syndrome and dementia typically include:
measures of cognition, neuropsychiatric features, adaptive behavior, or scores on subsequent standardized testing. Certainly, assessment of compliance and tolerance of these medications should be a priority in all first follow-up visits. Thereafter, response to medication and decision-making for continuing treatment is judged primarily based on subjective and objective findings during the interview and follow up memory testing. As the impact of these drugs is often subtle and the theoretical mechanism is to slow the progression of disease, if the patient is tolerating the medication, it is often generally justifiable to continue treatment until at least moderate-stage disease or beyond.
Over the course of the disease, regular support and education are critical. It is helpful to provide a general estimate of the stage of the disease (early, mid-stage, or late stage) to the caregiver, to help provide stage-specific education and expectations. Early stage disease warrants counseling regarding communication strategies, modification of expectations at home/day/work program, safety concerns, behavior or personality changes, and adapting level of supervision and support to account for short-term memory loss.
Anticipatory guidance is necessary to prepare caregivers for changes and for setting realistic expectations going forward. In the early stages of disease, it is recommended to educate caregivers on certain features that commonly accompany progression to midstage, including: dysphagia, mobility impairments, new or worsening urinary incontinence, and seizures. When the individual begins to exhibit changes consistent with mid-stage disease, anticipatory guidance should shift to more goal-directed discussions about future planning, advance directives, and goals of care. Having this discussion proactively allows for the caregiver to consider scenarios that may be encountered in latestage disease, while avoiding having to make decisions in a crisis situation.
One important complicating factor that adds a significant layer of complexity to this discussion when caring for individuals with I/DD is the issue of guardianship and/or
proper identification of a decision-maker. The discussion described above would ideally be held in-person during an office encounter with the health care proxy or guardian present. It is common for some older adults with I/DD to have a court-appointed guardian or health care proxy who may be a family member or someone else. Thus engaging the decision-maker in this important discussion may often be easier said than done, but nonetheless extremely important.
Need for future research and study
As more individuals with I/DD regularly reach old age, the need for further lifespan research within this field cannot be overstated. There is a dearth of syndrome-specific information that can provide insight into common co-incident conditions encountered as individuals progress into adulthood and old age. There remains conflicting information and uncertainty about the relative risk of dementia for adults with all forms of intellectual disability, and this is a major barrier to proper assessment, risk stratification, and guidance. The emerging field of adult developmental medicine has extensively fertile grounds for research, both in basic science and clinical areas, especially clinical trials.
This field remains small in number, but large in passion and commitment. Consensus guidelines are necessary to help standardize assessment practices among providers performing memory assessments in this growing population, and this is one of the primary aims of the NTG. In addition, continued training on lifespan issues for adults with I/DD needs to be incorporated into the general medical training of providers of adult medicine, and there are other national efforts underway in this regard. Lastly, the efforts of specialists currently working within this field need to be harnessed in a formal fashion and supported through funding opportunities, so that efforts such as those undertaken by this National Task Group can be continued. 
